Hematopoietic and Lymphoid Cell Neoplasm

Hematopoietic and Lymphoid Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

18,680 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 651–700 of 2,528 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01348919	Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma	completed	Phase 1 / Phase 2	11	Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY	2	Jun 28, 2023	clinicaltrials
NCT03028103	Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients	completed	Phase 1	32	Epizyme, Inc.